Skip to main content

Table 2 Characteristics of study subjects with and without NAFLD

From: Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years

Variables

Subjects with NAFLD

(n = 349)

Mean ± SD

Subjects without NAFLD (n = 927)

Mean ± SD

P value

Gender, n (%)

   

female

102 (29.2)

500 (53.7)

<.0001

male

247 (70.8)

427 (46.1)

 

Age

47.7 ± 11.5

38.0 ± 12.1

<.0001

BMI

29.7 ± 4.7

24.0 ± 3.7

<.0001

WHR

0.9 ± 0.1

0.8 ± 0.1

<.0001

ALT

20.9 ± 10.3

13.5 ± 5.8

<.0001

AST

11.2 ± 5.1

9.0 ± 2.6

<.0001

GGT

20.5 ± 20.6

11.0 ± 10.5

<.0001

TSH (μU/ml)

1.8 ± 1.4

1.8 ± 3.5

0.6381

TT3 (nmol/l)

1.6 ± 0.3

1.6 ± 0.3

0.3293

TT4 (nmol/l)

83.2 ± 15.6

92.0 ± 17.4

0.0004

Anti-TPO (IU/ml)

23.9 ± 72.1

23.9 ± 74.0

0.4063

Diabetes, n (%)

22 (6.3)

8 (0.9)

<.0001

Metabolic syndrome, n (%)

65 (18.6)

15 (1.6)

<.0001

Hypertension, n (%)

99 (28.4)

67 (7.2)

<.0001

  1. BMI = body-mass-index; WHR = waist to hip ratio; ALT = Alanine transaminase; AST = Aspartate transaminase; GGT = Gamma-glutamyl transferase; TSH = thyroid-stimulating hormone; TT3 = triiodothyronine; TT4 = thyroxine; Anti-TPO = anti-thyroid autoantibodies